Table 2.
Parameter | Description | Estimate | 95% CI |
---|---|---|---|
CL (L/h) | Apparent clearance | 8.52 | 7.70–9.64 |
V0 (L) | Apparent volume of distribution at baseline | 565 | 468–686 |
MTT (h) | Mean transit time | 0.367 | 0.34–0.39 |
VLmax (fraction) | Maximum fraction of volume decrease | 0.805 | 0.771–0.839 |
VLA50 (μg) | Amount in the central compartment resulting in 50% of the maximum volume decrease | 3.36 | 2.16–5.21 |
Ntr | Number of transit compartments | 5.81 | 4.29–7.26 |
Kgut (1/h) | Gut extraction rate constant | 1.89 | 1.16–2.88 |
Kout (1/h) | Gut extraction degradation rate constant | 0.00205 | (Fixed) |
S | Scaling factor for the effect of Aa on Kout | 22.0 | 13.8–30.5 |
WTV0 | Effect of body weight on V0 | 1.00 | (Fixed) |
FOODMTT | Effect of food on MTT | 3.39 | (Fixed) |
RUVearly | Maximum value of time-varying RUV immediately after dosing | 1.20 | 0.811–1.77 |
RUVlate | Minimum value of time-varying RUV | 0.216 | 0.201֪–0.232 |
RUVrate (1/h) | RUV decrease rate | 1.32 | 0.992–1.670 |
RUVadd | Additive RUV component | 0.000625a | (Fixed) |
AGEslope | Slope in the CL–age maturation function | 0.267 | 0.106–0.447 |
AGE50 (years) | Age where 50% of adult CL/F is reached | 5.34 | 1.36–6.89 |
IIVCL | Variance on CL/F | 0.150b | 0.120–0.177 |
IIVV0 | Variance on V0 | 0.0944b | 0.0628–0.1320 |
IIVMTT | Variance on MTT | 0.0423b | 0.0232–0.0661 |
95% CI calculated from a 500-sample bootstrap, with 457 successful minimizations
The time-varying (proportional) RUV model was implemented as , where RUVprop is the proportional RUV component and TAD is time after dosing
aThe additive RUV component was fixed to a value equivalent to 0.025 ng/mL standard deviation, corresponding to 50% of the assay lower limit of quantitation
bIIV values are reported as variance estimates in the log-normal distribution. Coefficient of variation was 39% for IIVCL, 31% for IIVV0 and 21% for IIVMTT. Shrinkage was 4.5% for IIVCL, 17.4% for IIVV0, and 40.8% for IIVMTT